Evidence map›Paper›PMID 42252329›Full record

ArticleEuropean journal of pediatrics2026

Long-term effects of hematopoietic stem cell transplantation on endocrine function in childhood and adolescence: a single tertiary care center study.

Sundus Aziz, Ali AlGhamdi, Emily Heaphy, Nabil AlEysaye, Marwa Elhadidi, Muhammad Khubaib Shahzad, Abdullateef Ahmed, Hesham Aboelghar, Abdulmajid Almahbosh, Mrouge Sobahi and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sundus AzizDepartment of Pediatrics, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Ali AlGhamdiDepartment of Pediatrics, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Emily HeaphyResearch Center, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Nabil AlEysayeDepartment of Pediatrics, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Marwa ElhadidiDepartment of Pediatric Hematology Oncology, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Muhammad Khubaib ShahzadDepartment of Pediatric Hematology Oncology, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Abdullateef AhmedDepartment of Pediatric Hematology Oncology, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Hesham AboelgharDepartment of Pediatric Hematology Oncology, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Abdulmajid AlmahboshDepartment of Pediatrics, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Mrouge SobahiDepartment of Pediatrics, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Mohammad BayoumyDepartment of Pediatric Hematology Oncology, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia.
Noman AhmadDepartment of Pediatrics, King Faisal Specialists Hospital & Research Center, Jeddah, Saudi Arabia. anoman@kfshrc.edu.sa.ORCID http://orcid.org/0000-0002-4841-8380

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study is to evaluate long-term endocrine dysfunctions in pediatric hematopoietic stem cell transplantation (HSCT) survivors. This retrospective study analyzed 141 pediatric HSCT recipients (75 males, 66 females). Endocrine outcomes, including gonadal dysfunction, hypothyroidism, growth hormone deficiency, and adrenal insufficiency, were assessed through clinical evaluations and laboratory tests. Statistical analyses examined associations between conditioning regimens and endocrine complications. Endocrine dysfunction was diagnosed in 46.1% of patients, with a higher prevalence in females (72.7% vs. 22.7% in males). The most striking finding was gonadal dysfunction, which occurred exclusively in girls, and occurred in 72% of female patients, all of whom received myeloablative conditioning. Hypothyroidism was seen in approximately 20% of patients, while growth hormone deficiency and adrenal insufficiency occurred in 3% and 9% of patients respectively.

conclusionThe study highlights the gender-specific vulnerabilities in endocrine outcomes following HSCT, emphasizes the critical importance of long-term endocrine surveillance and early interventions to mitigate the burden of these complications, and stresses the necessity of optimizing guidelines for endocrine care in this vulnerable population, ultimately enhancing quality of life and long-term outcomes for HSCT survivors. WHAT IS KNOWN: • Hematopoietic stem cell transplantation (HSCT) is an important curative therapy for several debilitating and life-threatening conditions, but this is associated with many endocrine dysfunctions. • There is currently a lack of standardized screening guidelines based on timing, age, and gender for detecting endocrine disorders in children who survived HSCT. WHAT IS NEW: • Endocrine dysfunction was diagnosed in 46.1% of patients, with a higher prevalence in females (72.7% vs. 22.7% in males); the gonadal dysfunction with no pubertal onset and absent secondary sexual characteristics occurred exclusively in girls. • Reduced intensity conditioning regimens can reduce the endocrine dysfunction, while standard screening protocols can improve early diagnosis and management.

Indexed as

Endocrine System DiseasesHematopoietic Stem Cell TransplantationAdolescentAdrenal InsufficiencyChildChild, PreschoolFemaleGonadal DisordersHumansHypothyroidismInfantMalePrevalenceRetrospective StudiesTertiary Care CentersAdrenal insufficiencyDelayed pubertyEndocrine diseaseGonadal disorderGrowth hormone deficiencyHematopoietic stem cell transplantationHypothyroidism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.